Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Dose-Exploration, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Qin Qiao Yan Shu Granules in the Treatment of Acute Pharyngitis (Exterior Wind-Heat Syndrome)

NCT06932328 is registered in ClinicalTrials.gov with Jianmin Pharmaceutical Group Co., LTD. as lead sponsor.

NCT NCT06932328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06932328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Dose-Exploration, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Qin Qiao Yan Shu Granules in the Treatment of Acute Pharyngitis (Exterior Wind-Heat Syndrome)
Lead sponsor
Jianmin Pharmaceutical Group Co., LTD.
Phase
Phase 2
Overall status
Recruiting
Start date
March 26, 2025
Completion date
December 31, 2025
Enrollment
216 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

acute pharyngitis